Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;9(1):e14681.
doi: 10.14814/phy2.14681.

Skeletal muscle proteins important for work capacity are altered with type 2 diabetes - Effect of 10-20-30 training

Affiliations

Skeletal muscle proteins important for work capacity are altered with type 2 diabetes - Effect of 10-20-30 training

Thomas Baasch-Skytte et al. Physiol Rep. 2021 Jan.

Abstract

The study examined whether men with type 2 diabetes exhibit lower expression of muscle proteins important for exercise capacity, and whether exercise training promotes adaptations in these proteins. In a cross-sectional and longitudinal study, conducted at the University of Copenhagen. Twelve men with type 2 diabetes (T2D) were compared to eleven nondiabetes counterparts (ND) matched for age and body composition (body fat percentage). T2D underwent 10 weeks of high-intensity interval exercise training (10-20-30 training). T2D had lower expression of SOD1 (-62%; p < 0.001) and ETC complex V (-34%; p = 0.003), along with higher expression of ETC complex IV (+66%; p = 0.007), MFN2 (+62%; p = 0.001), and DRP1 (+30%; p = 0.028) compared to ND. T2D had higher (p < 0.001) expression of Na+ /K+ α1 (+98%), α2 (+114%), and NHE1 (+144%) than ND. In T2D, training increased exercise capacity (+9%; p < 0.001) as well as expression of SOD2 (+44%; p = 0.029), ETC complex II (+25%; p = 0.035), III (+52%; p = 0.041), IV (+23%; p = 0.005), and V (+21%; p = 0.035), CS activity (+32%; p = 0.006) as well as Na+ /K+ α1 (+24%; p = 0.034), Kir6.2 (+36%; p = 0.029), and MCT1 (+20%; p = 0.007). Men with type 2 diabetes exhibited altered expression of a multitude of skeletal muscle proteins important for exercise capacity. Ten weeks of 10-20-30 training upregulated expression of muscle proteins regulating antioxidant defense, mitochondrial function, and ion handling while enhancing exercise capacity in men with type 2 diabetes.

Trial registration: ClinicalTrials.gov NCT03349944.

Keywords: antioxidant defense; high-intensity interval training; ion handling; mitochondria.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Flowchart of subjects through the study
FIGURE 2
FIGURE 2
Average heart rate (excluding the 10‐min warm‐up period) (a) and average time spent in heart rate zones (b) during 10 weeks of 10‐20‐30 training in male type 2 diabetes patients (T2D; n = 12). Data are presented as mean ± SD
FIGURE 3
FIGURE 3
Expression of superoxide dismutase 1 (SOD1), superoxide dismutase 2 (SOD2), and catalase in male type 2 diabetes patients (T2D; SOD1; n = 9, SOD2; n = 10, Catalase; n = 10) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, N = 11). Data are presented as mean ± SD including individual values. †††Different (p < 0.001) from ND. *Different (p < 0.05) from T2D pre
FIGURE 4
FIGURE 4
Expression of subunits of the electron transport chain (ETC) complex I–V and maximal citrate synthase (CS) activity in male type 2 diabetes patients (T2D, ETC n = 11, CS activity n = 8) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, n = 11). Data are presented as mean ±SD including individual values. ††Different (p < 0.01) from ND. *Different (p < 0.05) from T2D pre. **Different (p < 0.05) from T2D pre
FIGURE 5
FIGURE 5
Maximal citrate synthase (CS) activity in male type 2 diabetes patients (T2D, n = 8) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, n = 11). Data are presented as mean ± SD including individual values. **Different (p < 0.05) from T2D pre
FIGURE 6
FIGURE 6
Expression of Mitofusin‐2 (MFN2) and Dynamin‐related protein 1 (DRP1) in male type 2 diabetes patients (T2D; n = 11) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, n = 11). Data are presented as mean ± SD including individual values.Different (p < 0.05) from ND.††Different (p < 0.01) from ND
FIGURE 7
FIGURE 7
Expression of muscle Na+/K+α1, α2, and β1 subunit, Phospholemman (FXYD1), and Kir6.2 in male type 2 diabetes patients (T2D, Na+/K+α1; n = 11. Na+/K+α2; n = 12. Na+/K+β1; n = 12. FXYD1; n = 12. Kir6.2; n = 11) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, n = 11). Data are presented as mean ± SD including individual values.†††Different (p < 0.001) from ND. *Different (p < 0.05) from T2D pre
FIGURE 8
FIGURE 8
Expression of Monocarboxylate transporter 1 and 4 (MCT1, MCT4) and sodium‐hydrogen exchanger 1 (NHE1) in male type 2 diabetes patients (T2D, MCT1/4 n = 6; NHE1; n = 10) before (pre) and after (post) 10 weeks of 10‐20‐30 training and in matched nondiabetes counterparts (ND, MCT1/4 n = 6, NHE1 n = 11). Data are presented as mean ± SD including individual values. †††Different (p < 0.001) from ND. **Different (p < 0.01) from T2D pre

Similar articles

Cited by

References

    1. Allen, D. G. , Lamb, G. D. , & Westerblad, H. (2008). Skeletal muscle fatigue: cellular mechanisms. Physiological Reviews, 88(1), 287–332. - PubMed
    1. Aouacheri, O. , Saka, S. , Krim, M. , Messaadia, A. , & Maidi, I. (2015). The investigation of the oxidative stress‐related parameters in type 2 diabetes mellitus. Canadian Journal of Diabetes, 39(1), 44–49. - PubMed
    1. Baasch‐Skytte, T. , Lemgart, C. T. , Oehlenschlager, M. H. , Petersen, P. E. , Hostrup, M. , Bangsbo, J. , & Gunnarsson, T. P. (2020). Efficacy of 10–20‐30 training versus moderate‐intensity continuous training on HbA1c, body composition and maximum oxygen uptake in male patients with type 2 diabetes: A randomized controlled trial. Diabetes, Obesity & Metabolism, 22(5). - PubMed
    1. Bach, D. , Naon, D. , Pich, S. , Soriano, F. X. , Vega, N. , Rieusset, J. , Laville, M. , Guillet, C. , Boirie, Y. , Wallberg‐Henriksson, H. , Manco, M. , Calvani, M. , Castagneto, M. , Palacín, M. , Mingrone, G. , Zierath, J. R. , Vidal, H. , & Zorzano, A. (2005). Expression of Mfn2, the Charcot‐Marie‐Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin‐6. Diabetes, 54(9), 2685–2693. - PubMed
    1. Baldi, J. C. , Aoina, J. L. , Oxenham, H. C. , Bagg, W. , & Doughty, R. N. (2003). Reduced exercise arteriovenous O2 difference in Type 2 diabetes. Journal of Applied Physiology, 94(3), 1033–1038. - PubMed

Publication types

Associated data